Afuco™ Anti-Human RSPO3 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-RSPO3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Anti-RSPO3 is the first drug in its class to target the R-spondin-LGR pathway, and has shown robust preclinical activity against a number of solid tumor types.
Supplier Creative Biolabs
Product # AFC-726CL
Pricing Inquiry
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Target RSPO3
Species Reactivity Human
Feedback